Literature DB >> 30244697

Synthetic Biology Ethics at iGEM: iGEMer Perspectives.

Christopher M Whitford1, Nils-Christian Lübke2, Christian Rückert3.   

Abstract

The Human Practice (HP) work of the international Genetically Engineered Machine (iGEM) competition can serve as a great example of integrating ethical considerations into synthetic biology research. By highlighting three independent perspectives from those involved in various aspects of iGEM, here we aim to provide an informative picture of how ethical issues are approached within the iGEM competition.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ethics; human practice; iGEM; synthetic biology

Mesh:

Year:  2018        PMID: 30244697     DOI: 10.1016/j.tibtech.2018.06.004

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  2 in total

1.  Developing a Comprehensive, Adaptive, and International Biosafety and Biosecurity Program for Advanced Biotechnology: The iGEM Experience.

Authors:  Piers Millett; Thomas Binz; Sam Weiss Evans; Todd Kuiken; Ken Oye; Megan J Palmer; Cécile van der Vlugt; Kathrina Yambao; Samuel Yu
Journal:  Appl Biosaf       Date:  2019-06-01

Review 2.  Addressing the dark matter of gene therapy: technical and ethical barriers to clinical application.

Authors:  Kateryna Kratzer; Landon J Getz; Thibaut Peterlini; Jean-Yves Masson; Graham Dellaire
Journal:  Hum Genet       Date:  2021-04-08       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.